2016
DOI: 10.7314/apjcp.2016.17.2.609
|View full text |Cite
|
Sign up to set email alerts
|

Cost-Effectiveness Analysis of Breast Cancer Screening in Rural Iran

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 22 publications
0
18
0
Order By: Relevance
“…The acceptable coverage of screening not only depends on developing well-organized national policies, but also needs interventions to improve knowledge and create a positive attitude toward screening methods in the population at risk ( 39 ). A study of the rural areas of Iran demonstrated that the cost-effectiveness of screening programs significantly depended on the extent of participation, highlighting the importance of focusing on improving knowledge and acceptance ( 40 ). Almost all MENA countries lack a nationally organized cancer screening program and have numerous cultural and socioeconomic barriers toward screening ( 5 , 41 , 42 ).…”
Section: Discussionmentioning
confidence: 99%
“…The acceptable coverage of screening not only depends on developing well-organized national policies, but also needs interventions to improve knowledge and create a positive attitude toward screening methods in the population at risk ( 39 ). A study of the rural areas of Iran demonstrated that the cost-effectiveness of screening programs significantly depended on the extent of participation, highlighting the importance of focusing on improving knowledge and acceptance ( 40 ). Almost all MENA countries lack a nationally organized cancer screening program and have numerous cultural and socioeconomic barriers toward screening ( 5 , 41 , 42 ).…”
Section: Discussionmentioning
confidence: 99%
“…Their study also emphasized that a great number of cases with the breast cancer are found through the screening method. 11 …”
Section: Introductionmentioning
confidence: 99%
“…All conducted a full economic evaluation and cost-effectiveness analysis. A variety of perspectives were used, including that of the payer [22][23][24][25] ; society [26][27][28][29] ; healthcare provider 30,31 ; health system 32 ; government [33][34][35] ; and program perspective. 36 Time horizons to capture benefit, cost, and resources were reported in 13 studies, in the range of 5 months to a lifetime.…”
Section: Study Characteristicsmentioning
confidence: 99%
“…Twelve studies included only direct and recurrent costs, having excluded any start-up costs, [22][23][24][25][26][27][28][30][31][32][33][34]36 while 3 studies were considered to have included indirect costs in their analysis. 28,29,34 In terms of health outcomes, 9 studies reported one of the following primary health outcomes: years of survival, life expectancy, number of breast cancer deaths averted, mortality reduction, or disability-adjusted life-years (DALY).…”
Section: Study Characteristicsmentioning
confidence: 99%